Holding back Chinese technology like DeepSeek and TikTok could be good for America, but it also hurts America.

Learn more about whether Catalyst Pharmaceuticals, Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Analysts have set 12-month price targets for Regeneron Pharmaceuticals, revealing an average target of $945.56, a high ...

Vertex's lineup will look transformed in five years, and the company should continue performing well beyond that time. It's ...

Abbott also is a buy for its dividend strength. As a Dividend King it's raised its dividend for more than 50 consecutive ...

NerdWallet, Inc. does not offer advisory or brokerage services, nor does it recommend or advise investors to buy or sell particular stocks, securities or other investments. Amazon's success is ...

The stock market chugged along this week after Wall Street finally got good news on inflation. The Dow is up 382 points, or 0.9%, and 4% on the week. The Nasdaq Composite is up 1.7% today and 2.7% on ...

A look at Intellia Therapeutics, Inc. and Editas Medicine, Inc., including their restructuring and pipeline prioritization. Read more about EDIT and NTLA stocks here.

Shares of CRISPR Therapeutics CRSP have lost more than ... sector’s downturn have left investors confused about whether to buy, hold, or sell the stock. Let’s delve into the company’s ...

Shares of CRISPR Therapeutics CRSP have lost more than 30% in the past ... and the drug/biotech sector’s downturn have left investors confused about whether to buy, hold, or sell the stock. Let’s ...